Effect of chronic kidney disease on red blood cell rheology

Clinical Hemorheology and Microcirculation

Volumn 34, Issue 3, 2006, Pages 411-420

  Brimble, K Scott ^a,d   McFarlane, Andrew ^b   Winegard, Nancy ^c   Crowther, Mark ^a   Churchill, David N ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON REGIONAL LABORATORY MEDICINE PROGRAM   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d NONE   (Canada)

Author keywords

Deformability; Erythrocyte; Hemodialysis; Viscosity

Indexed keywords

ERYTHROPOIETIN;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD RHEOLOGY; BLOOD VISCOSITY; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FUNCTION; MALE; PROTEIN DEFICIENCY; RETICULOCYTE COUNT; SAMPLE SIZE; SHEAR RATE; SHEAR STRESS; VISCOMETER;

AGED; ANALYSIS OF VARIANCE; BLOOD VISCOSITY; CASE-CONTROL STUDIES; DIABETIC NEPHROPATHIES; ERYTHROCYTE AGING; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTES; ERYTHROPOIETIN, RECOMBINANT; FEMALE; HEMORHEOLOGY; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC;

EID: 33645410980     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. D. Bareford, G.S. Lucas, P.C.W. Stone, N.M. Caldwell, R. McGonigle and J. Stuart, Erythrocyte deformability in chronic renal failure, Clin. Hemorheol. 6 (1986), 501-510.
2. O.K. Baskurt and H.J. Meiselman, Cellular determinants of low-shear blood viscosity, Biorheology 34 (1997), 235-247.
3. C.D. Brown, Z.H. Zhao, L.L. Thomas, R. deGroof and E.A. Friedman, Effects of erythropoietin and aminoguanidine on red blood cell deformability in diabetic azotemic and uremic patients, Am. J. Kidney Dis. 38 (2001), 1414-1420.
4. N. Casson, A flow equation for pigment-oil suspensions of the printing ink type, in: Rheology of Disperse Systems, C. Mills, ed., Pergamon Press, New York, 1959.
5. D.W. Cockcroft and M.H. Gault, Prediction of creatinine clearance from serum creatinine, Nephron 16 (1976), 31-41.
6. J. Cohen, Statistical Power for the Social Sciences, 2nd edn, Academic Press, New York, 1977.
7. C.H. Cole, Decreased ouabain-sensitive adenosine triphosphatase activity in the erythrocyte membrane of patients with chronic renal disease, Clin. Sci. Mol. Med. 45 (1973), 775-784.
8. L. Dintenfass, Blood as a near-"ideal" emulsion: a retrospective on the concept of the red cell as a fluid drop, its implications for the structure of the red cell membrane, Biorheology 27 (1990), 149-161.
9. D. Docci, C. del Vecchio, P. Salvi, F. Turci, G. Salvi, L. Cenciotti and E. Pretolani, Osmotic fragility of erythrocytes, cell deformability and secondary hyperparathyroidism in uremic patients on maintenance hemodialysis, Clin. Nephrol. 23 (1985), 68-73.
10. D. Docci, F. Turci, P. Salvi and E. Pretolani, Red blood cell deformability and secondary hyperparathyroidism in uremic patients on maintenance hemodialysis, Artif. Organs 8 (1984), 141-144.
11. A.J. Erslev and A. Besarab, The rate and control of baseline red cell production in hematologically stable patients with uremia, J. Lab. Clin. Med. 126 (1995), 283-286.
12. J.W. Eschbach Jr., D. Funk. J. Adamson, I. Kuhn, B.H. Scribner and C.A. Finch, Erythropoiesis in patients with renal failure undergoing chronic dialysis, N. Engl. J. Med. 276 (1967), 653-658.
13. U. Gafter, T. Malachi, H. Barak, M. Djaldetti and J. Levi, Red blood cell calcium homeostasis in patients with end-stage renal disease, J. Lab. Clin. Med. 114 (1989), 222-231.
14. C.W. Haest, G.K. Driessen, D. Kamp, H. Heidtmann, T.M. Fischer and M. Stohr-Liesen, Is "deformability" a parameter for the rate of elimination of erythrocytes from the circulation?, Pflugers Arch. 388 (1980), 69-73.
15. F.F. Ibrahim, M.M. Ghannam and F.M. Ali, Effect of dialysis on erythrocyte membrane of chronically hemodialyzed patients, Ren. Fail. 24 (2002), 779-790.
16. W. Inauen, M. Staubli, C. Descoeudres, R.L. Galeazzi and P.W. Straub, Erythrocyte deformability in dialysed and non-dialysed uraemic patients, Eur. J. Clin. Invest. 12 (1982), 173-176.
17. International Committee for Standardization in Hematology (Expert Panel on Blood Rheology), Guidelines for the measurement of blood viscosity and erythrocyte deformability, Clin. Hemorheol. 6 (1986), 439-453.
18. R.A. Joske, J.M. McAlister and T.A. Prankerd, Isotope investigations of red blood cell production and destruction in chronic renal disease, Clin. Sci. 15 (1956), 511-522.
19. Y. Kikuchi, T. Koyama, Y. Koyama, S. Tozawa, T. Arai, M. Horimoto and Y. Kakiuchi, Red blood cell deformability in renal failure, Nephron 30 (1982), 8-14.
20. J. Kletzmayr, G. Mayer, E. Legenstein, G. Heinz-Peer, T. Leitha, W.H. Horl and J. Kovarik, Anemia and carnitine supplementation in hemodialyzed patients, Kidney Int. Suppl. 69 (1999), S93-106.
21. S. Kobayashi, H. Moriya, K. Aso and T. Ohtake, Vitamin E-bonded hemodialyzer improves atherosclerosis associated with a rheological improvement of circulating red blood cells, Kidney Int. 63 (2003), 1881-1887.
22. R. Koppensteiner, F. Stockenhuber, C. Jahn, P. Balcke, E. Minar and H. Ehringer, Changes in determinants of blood rheology during treatment with haemodialysis and recombinant human erythropoietin, BMJ 300 (1990), 1626-1627.
23. T. Linde, B. Sandhagen, B.G. Danielson and B. Wikstrom, Impaired erythrocyte fluidity during treatment of renal anaemia with erythropoietin, J. Intern. Med. 231 (1992), 601-606.
24. T. Linde, B. Sandhagen, B. Wikstrom and B.G. Danielson, The required dose of erythropoietin during renal anaemia treatment is related to the degree of impairment in erythrocyte deformability, Nephrol. Dial. Transplant 12 (1997), 2375-2379.
25. E.T. Lonergan, M. Semar and K. Lange, A dialyzable toxic factor in uremia, Trans. Am. Soc. Artif. Intern. Organs 16 (1970), 269-271.
26. E.T. Lonergan, M. Semar, R.B. Sterzel, G. Treser, M.A. Needle, L. Voyles and K. Lange, Erythrocyte transketolase activity in dialyzed patients. A reversible metabolic lesion of uremia, N. Engl. J. Med. 284 (1971), 1399-1403.
27. G.D.O. Lowe and J.C. Barbenel, Plasma and blood viscosity, in: Clinical Blood Rheology, G.D.O. Lowe, ed., CRC Press Inc., Boca Raton, FL, 1988, pp. 12-44.
28. J. Ly, R. Marticorena and S. Donnelly, Red blood cell survival in chronic renal failure. Am. J. Kidney Dis. 44 (2004), 715-719.
29. I.C. Macdougall, M.E. Davies, R.D. Hutton, G.A. Coles and J.D. Williams, Rheological studies during treatment of renal anaemia with recombinant human erythropoietin, Br. J. Haematol. 77 (1991), 550-558.
30. I.C. Macdougall, M.E. Davies, R.D. Hutton, I. Cavill, N.P. Lewis, G.A. Coles and J.D. Williams, The treatment of renal anaemia in CAPD patients with recombinant human erythropoietin, Nephrol. Dial. Transplant. 5 (1990), 950-955.
31. M. Martinez, A. Vaya, J. Alvarino, J.L. Barbera, D. Ramos, A. Lopez and J. Aznar, Hemorheological alterations in patients with chronic renal failure. Effect of hemodialysis, Clin. Hemorheol. Microcirc. 21 (1999), 1-6.
32. L.T. McGrath, A.F. Douglas, E. McClean, J.H. Brown, C.C. Doherty, G.D. Johnston and G.P. Archbold, Oxidative stress and erythrocyte membrane fluidity in patients undergoing regular dialysis, Clin. Chim. Acta 235 (1995), 179-188.
33. G. Passavanti, G. Cicco, G. Baldassarre, P. Vicenti, F. Soleti, G.D. Stingi, M.C. Carbonara, P. Coratelli and A. Pirrelli, Tissular oxygenation and erythrocyte deformability in haemodialyzed patients using different dialytic membranes, Clin. Hemorheol. Microcirc. 21 (1999), 421-424.
34. M. Paulitschke, K. Ludat, E. Riedel and H. Hampl, Long-term effects of rhEPO therapy on erythrocyte rheology in dialysis patients with different target hematocrits, Clin. Nephrol. 53 (2000), S36-S41.
35. E. Peuchant, C. Motta, C. Salles and M. Clerc, A compensatory mechanism improving red cell membrane fluidity in hemodialysed patients, Clin. Chim. Acta 190 (1990), 57-66.
36. A.B. Schwartz, B. Kelch, L. Terzian, J. Prior, K.E. Kim, E. Pequinot and S.B. Kahn, One year of rHuEPO therapy prolongs RBC survival and may stabilize RBC membranes despite natural progression of chronic renal failure to uremia and need for dialysis, ASAIO Trans. 36 (1990), M691-M696.
37. A.B. Shaw, Haemolysis in chronic renal failure, Br. Med. J. 2 (1967), 213-216.
38. M.A. Srour, Y.Y. Bilto and M. Juma, Susceptibility of erythrocytes from non-insulin-dependent diabetes mellitus and hemodialysis patients, cigarette smokers and normal subjects to in vitro oxidative stress and loss of deformability, Clin. Hemorheol. Microcirc. 22 (2000), 173-180.
39. J. Stuart. Erythrocyte deformability, in: Clinical Blood Rheology, G.D.O. Lowe, ed., CRC Press Inc., Boca Raton, FL, 1988, pp. 66-85.
40. J. Stuart and G.B. Nash. Red cell deformability and haematological disorders, Blood Rev. 4 (1990), 141-147.
41. M. Viljoen, A.A. de Oliveira and F.J. Milne, Physical properties of the red blood cells in chronic renal failure, Nephron 59 (1991), 271-278.
42. X. Wang, S.K. Peesapati, M.F. Renedo and S. Moktan, Hemoglobin A1c levels in non-diabetic patients with end-stage renal disease (ESRD) receiving hemodialysis, J. Endocrino. Invest. 27 (2004), 733-735.
43. J. Wink, N.D. Vaziri, S. Barker, J. Hyatt and C. Ritchie, The effect of hemodialysis on whole blood, plasma and erythrocyte viscosity, Int. J. Artif. Organs 11 (1988), 340-342.
44. P. Zachee, M.A. Boogaerts, R.L. Lins, Van den Broeck and M.E. De Broe, Erythrocyte deformability in uremic hemodialyzed patients, Clin. Nephrol. 25 (1986), 315.